SYNTACOLL

Welcome to the Brand page for “SYNTACOLL”, which is offered here for Manufacturing pharmaceutical products for others; custom synthesis of collagen-based absorbable implants and wound dressings to the order and specification of others; custom manufacturing and processing services, manufacturing and processing of collagen-based absorbable implants and wound dressings to the specification of others;pharmaceutical, veterinary and sanitary preparations, in particular preparations containing collagen for treating wounds and burns; surgical implants comprising living tissue for wound healing and hemostatic purposes, except dental implants;implants consisting primarily of artificial materials for wound healing and hemostatic use, except dental implants;scientific research in the fields of collagen, chemicals and pharmaceuticals; product safety testing in the fields of collagen, chemicals and pharmaceuticals; research and development of new products for others in the fields of collagen, chemicals and pharmaceuticals; genotyping services for research or analysis related to genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; gene-sequencing-based tests for research purposes; design and development for others of collagen-based absorbable implants and wound dressings and methods for drug discovery; scientific research, development of pharmaceuticals and diagnostic methods for others;.

Its status is currently believed to be active. Its class is unavailable. “SYNTACOLL” is believed to be currently owned by “INNOCOLL PHARMACEUTICALS LIMITED”.